Advancing the field of drug delivery: taking aim at cancer

Marsha A Moses1, Henry Brem, Robert Langer

  • 1The Vascular Biology Program, Children's Hospital and the Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Cancer Cell
|December 12, 2003
PubMed

Insights

Advanced drug delivery systems improve cancer treatment efficacy. This review covers approved therapies like liposomal systems and transdermal patches, and future innovations such as smart microchips for better cancer drug delivery.

Area of Science:

  • Oncology and Pharmaceutical Sciences
  • Biomedical Engineering

Background:

  • Drug delivery systems (DDS) are integral to modern cancer therapeutics.
  • Millions of patients have benefited from existing DDS, leading to new treatment options and improved outcomes.

Purpose of the Study:

  • To review regulatory-approved and clinically utilized cancer drug delivery systems.
  • To discuss emerging "smart" drug delivery technologies and future challenges in the field.

Main Methods:

  • Review of regulatory-approved drug delivery systems for cancer therapeutics.
  • Discussion of current clinical applications including controlled delivery, local chemotherapy, polymer conjugates, liposomal systems, and transdermal patches.
  • Exploration of next-generation technologies like controlled release microchips.

Main Results:

  • Several drug delivery systems are approved and in clinical use, enhancing cancer therapy.
  • Established systems include controlled delivery, local chemotherapy, polymer drug conjugates, liposomal systems, and transdermal patches.
  • Future directions involve "smart" systems like controlled release microchips.

Conclusions:

  • Drug delivery systems have significantly advanced cancer treatment.
  • Current systems offer diverse therapeutic strategies, with ongoing innovation promising further improvements.
  • Future research should address challenges in developing and implementing next-generation smart drug delivery systems for oncology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...